AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2017
Mar 6, 2017
30016_dirs_2017-03-06_37f22e2e-f2f5-48f4-9269-426f9aac7d23.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2016-08-25
Reporting Person: HENDERSON REBECCA M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-25 | Common Stock | M | 9924 | $26.6550 | Acquired | 31374 | Direct |
| 2016-08-25 | Common Stock | S | 9924 | $110.4346 | Disposed | 21450 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-25 | Non-Qualified Stock Option (right-to-buy) | $26.6550 | M | 9924 | Disposed | 2017-02-13 | Common Stock (9924) | Direct |
Footnotes
F1: This Form 4 is being amended solely to correct the number of shares of common stock beneficially owned by the reporting person following the reported transactions on the date of the transactions.
F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,962 shares on February 14, 2011, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F3: Not applicable.